Medical Review Officer Services

The Regional Transportation District (RTD) in Denver, Colorado is seeking a Medical Review Officer (MRO) to provide comprehensive drug testing review and verification services in compliance with Department of Transportation (DOT), Federal Transit Administration (FTA), and Federal Railroad Administration (FRA) regulations. The procurement, designated as RFP 124DA012, is for a five-year contract from 2025 to 2029, with an estimated annual volume of 2,550 standard tests and 3 split specimen tests. The successful vendor must be a licensed physician certified to perform MRO services, responsible for reviewing and verifying drug test results, maintaining strict confidentiality, and providing electronic reporting. Key deliverables include monthly invoicing, quarterly review of at least 5% of chain of custody forms, and secure electronic transmission of test results. The proposal evaluation will be based on three primary criteria: approach to the Scope of Work (40% weight), cost (35% weight), and certification to provide tests for DOT employers (25% weight). A non-mandatory pre-proposal briefing is scheduled for October 15, 2024, via Microsoft Teams, with proposals due by 2:00 PM on November 4, 2024, and RTD anticipating a final selection by November 20, 2024.

While no specific Disadvantaged Business Enterprise (DBE) or Small Business Enterprise (SBE) participation goal is established, RTD encourages proposers to pursue subcontracting and partnering opportunities with DBE/SBE firms. The contract will be structured as a fixed-price agreement with a maximum price to be determined, requiring comprehensive insurance coverage including commercial general liability, automobile liability, workers' compensation, and umbrella/excess liability insurance with specified minimum coverage amounts. Proposers must submit detailed documentation, including technical proposals, organizational conflict of interest certifications, and financial information demonstrating capability and compliance. The contract includes provisions for monthly invoicing with detailed progress reports, with payment to be made within 30 days of RTD's approval. While the exact award value is not specified, the contract anticipates covering drug testing services for RTD's workforce over a five-year period, with unit costs to be submitted for both standard and split specimen tests for each contract year.